Karyopharm Therapeutics | KPTI - Dividend Yield


Karyopharm Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
AbbVie 3.1 0.19 Mar/2026
Abbott 2.38 0.46 Mar/2026
Amgen 2.78 0.17 Mar/2026
AstraZeneca USD 1.18 0.56 Mar/2026
BioCryst Pharmaceuticals 0 0 Mar/2025
Bristol-Myers Squibb 4.12 3.9 Mar/2026
Eli Lilly 0.58 0.16 Dec/2025
Enanta Pharmaceuticals 0 0 Mar/2025
GlaxoSmithKline 0.82 3.75 Mar/2026
J&J 2.16 0.34 Mar/2026
Karyopharm Therapeutics 0 0 Mar/2025
Merck 2.76 0.36 Mar/2026
Nektar Therapeutics 0 0 Mar/2025
Novartis USD 3.33 0.29 Mar/2026
Novartis 2.9 0.22 Dec/2025
Pfizer 6.91 0.33 Dec/2025
Regeneron Pharmaceuticals 0.46 0.01 Mar/2026
Roche Holding 2.96 0.8 Dec/2025
Sangamo BioSciences 0 0 Mar/2025
Takeda 4.08 0.46 Dec/2025